These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38277740)

  • 1. Tumor-derived lncRNAs: Behind-the-scenes mediators that modulate the immune system and play a role in cancer pathogenesis.
    Al-Hawary SIS; Saleh RO; Taher SG; Ahmed SM; Hjazi A; Yumashev A; Ghildiyal P; Qasim MT; Alawadi A; Ihsan A
    Pathol Res Pract; 2024 Feb; 254():155123. PubMed ID: 38277740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unveiling the functional paradigm of exosome-derived long non-coding RNAs (lncRNAs) in cancer: based on a narrative review and systematic review.
    Wu W; He J
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):15219-15247. PubMed ID: 37578522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNAs in tumor metabolic reprogramming and immune microenvironment remodeling.
    Yang J; Liu F; Wang Y; Qu L; Lin A
    Cancer Lett; 2022 Sep; 543():215798. PubMed ID: 35738332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Myeloid-derived Suppressor Cells by Long Non-coding RNAs in the Tumor Microenvironment and Tumorigenesis.
    Huo S; Liu L; Li Q; Wang J
    Discov Med; 2022; 33(170):143-151. PubMed ID: 36319601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment.
    Sun Z; Yang S; Zhou Q; Wang G; Song J; Li Z; Zhang Z; Xu J; Xia K; Chang Y; Liu J; Yuan W
    Mol Cancer; 2018 Apr; 17(1):82. PubMed ID: 29678180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of lncRNAs in cancer: Focusing on angiogenesis.
    Jin KT; Yao JY; Fang XL; Di H; Ma YY
    Life Sci; 2020 Jul; 252():117647. PubMed ID: 32275935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor immune microenvironment lncRNAs.
    Park EG; Pyo SJ; Cui Y; Yoon SH; Nam JW
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34891154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveying lncRNA-lncRNA cooperations reveals dominant effect on tumor immunity cross cancers.
    Shao T; Xie Y; Shi J; Yang C; Zou H; Li Y; Xu J; Li X
    Commun Biol; 2022 Dec; 5(1):1324. PubMed ID: 36463330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Long Non-Coding RNAs in the Tumor Immune Microenvironment.
    Guo Y; Xie Y; Luo Y
    Front Immunol; 2022; 13():851004. PubMed ID: 35222443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA loss in immune suppression in cancer.
    Hu Q; Egranov SD; Lin C; Yang L
    Pharmacol Ther; 2020 Sep; 213():107591. PubMed ID: 32473960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of lncRNAs and exosomal lncRNAs in cancer metastasis.
    Zhang Y; Zhao L; Bi Y; Zhao J; Gao C; Si X; Dai H; Asmamaw MD; Zhang Q; Chen W; Liu H
    Biomed Pharmacother; 2023 Sep; 165():115207. PubMed ID: 37499455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-cancer survey of lncRNA rewiring and functional alternation in tumor-infiltrating T cell by scLNC.
    Lei Y; Meng Q; Hong F; Zhao M; Gao X
    Cancer Lett; 2023 Aug; 569():216319. PubMed ID: 37468058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Annotated and Unannotated Long Noncoding RNAs from Exosome Subtypes Using Next-Generation RNA Sequencing.
    Suwakulsiri W; Chen M; Greening DW; Xu R; Simpson RJ
    Methods Mol Biol; 2021; 2254():195-218. PubMed ID: 33326077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNAs in cancer-immunity cycle.
    Yu WD; Wang H; He QF; Xu Y; Wang XC
    J Cell Physiol; 2018 Sep; 233(9):6518-6523. PubMed ID: 29574911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding RNAs (lncRNAs) in Response and Resistance to Cancer Immunosurveillance and Immunotherapy.
    Eptaminitaki GC; Wolff N; Stellas D; Sifakis K; Baritaki S
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy-mediated lncRNA-induced immune cell plasticity in cancer immunopathogenesis.
    Lu J; Ma H; Wang Q; Song Z; Wang J
    Int Immunopharmacol; 2024 Nov; 141():112967. PubMed ID: 39181018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The landscape of long non-coding RNAs in tumor stroma.
    Uddin MN; Wang X
    Life Sci; 2021 Jan; 264():118725. PubMed ID: 33166593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulatory role of long non- coding RNAs as a novel controller of immune response against cancer cells.
    Mofed D; Omran JI; Sabet S; Baiomy AA; Emara M; Salem TZ
    Mol Biol Rep; 2022 Dec; 49(12):11775-11793. PubMed ID: 36207500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential.
    Pi YN; Qi WC; Xia BR; Lou G; Jin WL
    Front Immunol; 2021; 12():697083. PubMed ID: 34295338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of long non-coding RNAs in breast cancer microenvironment.
    Yao W; Wang L; Liu F; Xia L
    Pathol Res Pract; 2023 Aug; 248():154707. PubMed ID: 37506626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.